Cathay General Hospital

Wait

Center for Genomic Medicine, National Cheng Kung University

TFDA-certified laboratory for maternal-fetal precision medicine The Center for Genomic Medicine (CGM) at National Cheng Kung University has been established for over 20 years and is one of the first genomic centers in Taiwan. Our team is committed to developing laboratory developed tests for genetic diagnosis and screening of maternal-fetal medicine with the quality objectives of “Profession, Excellence, Accuracy and Innovation”. Currently, we have established 14 genetic tests, and not only have all of them been certified by TAF (ISO 17025) in 2021, but we have also been approved by the Ministry of Health and Welfare as “Laboratory Developed Tests and Services (LDTS)” in May 2021, making us the first registered laboratory for genetic testing of maternal-fetal precision medicine in Taiwan and the first LDTS certified laboratory among domestic research institutions. All testing services at the our center are developed by ourselves, from sample collection, data analysis to report, all are done locally in Taiwan. Our one-stop testing service also ensures the accuracy of the test and that the test information will not be leaked, thus protecting the personal information of the participants. We hope that with the recognition of LDTS registration by the Ministry of Health and Welfare, we can provide the quality testing services developed by the Center for Genomic Medicine to the general public. Furthermore, the Center has been actively innovating and developing new AI-assisted identification systems for big data genetic testing programs to significantly improve accuracy and accelerate turn-around time. Among them, the intelligent cOmputing Noble Embryo (icONE) has demonstrated excellent precision in prediction of embryo implantation and has been awarded the 18th National Innovation Award in 2021 in the category of Intelligent Healthcare and Health Technology. In the future, we will devote ourselves to IVF services to help infertile couples and couples trying to conceive to succeed in a single treatment through “intelligent selection” and “precise implantation” , and to realize the core value of precision medicine with a human face. With the belief of “Your beloved, our precious”, we perform each test to the highest standard and provide a complete genetic consultation service, giving genuine trust and security to the people who entrust us with their testing. The Center for Genomic Medicine at National Cheng Kung University will continue to make efforts to transfer and apply its research and development results to clinical testing, so as to contribute to the precision medicine for women and children in Taiwan.

Central Taiwan Science Park

Under the leadership of the Central Science Park, biomedical manufacturers in the central region will be exhibited with minimally invasive medical materials, intelligent aids together. In this exhibition, the biomedical products are the main axis. The medical problem solutions will be presented in a situational manner. Also, the medical materials used in the medical device will be exhibited. This experience is enable Visitors quickly understand the characteristics of various types of medical material products by visual connections. The show will be benefit of the central medical material industry settlement.

ChainHome Biotech Inc.

1. AT M1 filling station
2. Masterflex peristaltic pump display

CHANG CHING BAO BIOTECHNOLOGY CO,LTD

CHANG CHING BAO BIOTECHNOLOGY CO,LTD

Chang Gung Medical Foundation

The Chang Gung Medical Foundation was established in 1976 by the founder of the Formosa Plastics Group (FPG).The Foundation has since established seven Chang Gung Memorial Hospitals in Taipei, Linkou, Keelung, Kaohsiung, Chiayi, Taoyuan. and Yunlin. The Foundation has also been entrusted by the government to operate Feng-Shan Hospital and Tucheng Hospital, as well as to assist in the operation of Dali Jen-Ai Hospital in Taichung. With more than 32,800 patients treated daily and 10,000 beds, the hospital\\\'s management philosophy is \\\"Benefit mankind with sincerity and diligence.\\\".
Chang Gung Hospital has the ability to care for patients with acute and critical illnesses and has a long history of quality improvement. As a multiple-time SNQ National Gold Award winner, Chang Gung Hospital is committed to maintaining and promoting the health of patients by continuing to innovate and improve quality to meet international standards.
The exhibition will be presented under the four main axes of \\\"Specialty Medical Treatments, Smart Hospital, Innovative R&D, and Public Welfare Glory\\\", including cancer diagnosis, precise targeting treatment, quality of care, and the achievements and applications of medical innovation. The exhibition will showcase the soft power of medical care with a variety of themes and will provide interactive and hands-on experience for the public to learn about the charm of technological treatment.
Chang Gung Medical Foundation\\\'s exhibit topics include:
Specialty Medical Treatments
1. Cell therapy
2. Cutting-edge- Proton Therapy
3. Sports Medicine
4. Minimally invasive surgery
5. IoT
6. Telemedicine
7. Intelligent healthcare assistance
Selected thirteen innovative, clinically applicable patent achievements and Automated dispensing cabinets.
Public Welfare Glory
Award-winning recognition of comprehensive medical and social care.

Changbin Show Chwan Memorial Hospital

Connecting People, Working Together

Changhua Christian Hospital

Changhua Christian Hospital (CCH) was founded in 1896; for over a century, CCH has been inspired by the love and saving grace of Jesus Christ. CCH is central Taiwan's most historical medical center, with over 4,000 ward beds and 8,500 employees in 9 healthcare systems. CCH built the first intelligent and green hospital in Taiwan to uplift workflow efficiency and an integrated healthcare system to deliver advanced but safe health services. CCH is constructing the 「Proton Therapy Center」 and anticipates providing the best service for cancer patients in the center of Taiwan.

In the face of sweeping changes in medical information technology and artificial intelligence (AI) evolution, CCH is committed to being a smart and green hospital with "excellent, innovative, and practice." CCH has been validated by HMISS Level-7, through advanced technologies, such as big data, AI, and IoT, to introduce the clinical decision support system (CDSS) and personalized precision medicine to provide safe and high-quality services for patients. With the vision of "Future Hospital," CCH integrated intelligent, green, and clean into the hospital operation to facilitate the ESG management strategy and promote environmental protection, hospital governance, and corporate social responsibility to achieve the sustainable development goals (SDGs) of global medical societies.

Charder Electronic Co., Ltd.

Wireless data integration saves time and ensures accurate transcription, which is absolutely vital in the field of medical measurement.

Charder provides EMR-compatible body measurement solutions for all your needs, including Body Composition Analyzers, Baby Scales, Bed Scales, Column Scales, Chair Scales, Infant Scales, Wheelchair Scales, and more!

Charsire Biotechnology Corp.

Since establishment, Charsire Biotech. has been committed to the research and development of topically applied botanical preparation. With 20 years of experience in development of topical preparations and the US FDA quality guideline for botanical drugs , Charsire optimally arranges and manages the production process from raw materials, semi-finished products to finished products. Also, the main ingrediants sources of Sanovazo comes from soybean. Soybean is not only a stable source, but also easy to obtain and have a reasonable price, which makes the cost of Sanovazo quite competitive. Sanovazo trauma dressing is one of the few products for caring for the side effects of radiotherapy. In terms of clinical efficacy, it can effectively minimize the side effects of radiation therapy on the skin. The safety of Sanovazo trauma dressing has completed the pre-clinical toxicology study for topical new drugs. Sanovazo has highly completed its functionality and safety.